435 related articles for article (PubMed ID: 30107196)
1. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
Hu Y; Yang Q; Liu B; Dong J; Sun L; Zhu Y; Su H; Yang J; Yang F; Chen X; Jin Q
J Infect; 2019 Apr; 78(4):317-322. PubMed ID: 30107196
[TBL] [Abstract][Full Text] [Related]
2. Gut Mycobiota Dysbiosis in Pulmonary Tuberculosis Patients Undergoing Anti-Tuberculosis Treatment.
Cao D; Liu W; Lyu N; Li B; Song W; Yang Y; Zhu J; Zhang Z; Zhu B
Microbiol Spectr; 2021 Dec; 9(3):e0061521. PubMed ID: 34908436
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy.
Namasivayam S; Maiga M; Yuan W; Thovarai V; Costa DL; Mittereder LR; Wipperman MF; Glickman MS; Dzutsev A; Trinchieri G; Sher A
Microbiome; 2017 Jul; 5(1):71. PubMed ID: 28683818
[TBL] [Abstract][Full Text] [Related]
4. The Microbiota of Human Lung of Pulmonary Tuberculosis and the Alteration Caused by Anti-tuberculosis Drugs.
Zhang M; Shen L; Zhou X; Chen H
Curr Microbiol; 2022 Sep; 79(11):321. PubMed ID: 36121489
[TBL] [Abstract][Full Text] [Related]
5. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients.
Hu Y; Feng Y; Wu J; Liu F; Zhang Z; Hao Y; Liang S; Li B; Li J; Lv N; Xu Y; Zhu B; Sun Z
Front Cell Infect Microbiol; 2019; 9():90. PubMed ID: 31001490
[TBL] [Abstract][Full Text] [Related]
6. Profiling the airway in the macaque model of tuberculosis reveals variable microbial dysbiosis and alteration of community structure.
Cadena AM; Ma Y; Ding T; Bryant M; Maiello P; Geber A; Lin PL; Flynn JL; Ghedin E
Microbiome; 2018 Oct; 6(1):180. PubMed ID: 30301469
[TBL] [Abstract][Full Text] [Related]
7. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
[TBL] [Abstract][Full Text] [Related]
8. Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans.
Huang SF; Yang YY; Chou KT; Fung CP; Wang FD; Su WJ
Eur J Clin Invest; 2019 May; 49(5):e13068. PubMed ID: 30620398
[TBL] [Abstract][Full Text] [Related]
9. Distinct lung microbial community states in patients with pulmonary tuberculosis.
Hu Y; Kang Y; Liu X; Cheng M; Dong J; Sun L; Zhu Y; Ren X; Yang Q; Chen X; Jin Q; Yang F
Sci China Life Sci; 2020 Oct; 63(10):1522-1533. PubMed ID: 32303963
[TBL] [Abstract][Full Text] [Related]
10. Gut bacterial and fungal dysbiosis in tuberculosis patients.
Han M; Wang X; Zhang J; Su L; Ishaq HM; Li D; Cui J; Zhao H; Yang F
BMC Microbiol; 2024 Apr; 24(1):141. PubMed ID: 38658829
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.
Wipperman MF; Fitzgerald DW; Juste MAJ; Taur Y; Namasivayam S; Sher A; Bean JM; Bucci V; Glickman MS
Sci Rep; 2017 Sep; 7(1):10767. PubMed ID: 28883399
[TBL] [Abstract][Full Text] [Related]
12. Longitudinal profiling of gut microbiome among tuberculosis patients under anti-tuberculosis treatment in China: protocol of a prospective cohort study.
Shi W; Hu Y; Zheng X; Ning Z; Wu M; Xia F; Prast-Nielsen S; Hu YOO; Xu B
BMC Pulm Med; 2019 Nov; 19(1):211. PubMed ID: 31711450
[TBL] [Abstract][Full Text] [Related]
13. Gut Microbiome and Serum Metabolome Alterations Associated with Isolated Dystonia.
Ma L; Keng J; Cheng M; Pan H; Feng B; Hu Y; Feng T; Yang F
mSphere; 2021 Aug; 6(4):e0028321. PubMed ID: 34346706
[TBL] [Abstract][Full Text] [Related]
14. The influence of gut microbiota dysbiosis to the efficacy of 5-Fluorouracil treatment on colorectal cancer.
Yuan L; Zhang S; Li H; Yang F; Mushtaq N; Ullah S; Shi Y; An C; Xu J
Biomed Pharmacother; 2018 Dec; 108():184-193. PubMed ID: 30219675
[TBL] [Abstract][Full Text] [Related]
15. Impact of a Moderately Hypocaloric Mediterranean Diet on the Gut Microbiota Composition of Italian Obese Patients.
Pisanu S; Palmas V; Madau V; Casula E; Deledda A; Cusano R; Uva P; Vascellari S; Boi F; Loviselli A; Manzin A; Velluzzi F
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899756
[TBL] [Abstract][Full Text] [Related]
16. Alterations in the gut microbiota of patients with acquired immune deficiency syndrome.
Zhou Y; Ou Z; Tang X; Zhou Y; Xu H; Wang X; Li K; He J; Du Y; Wang H; Chen Y; Nie Y
J Cell Mol Med; 2018 Apr; 22(4):2263-2271. PubMed ID: 29411528
[TBL] [Abstract][Full Text] [Related]
17. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis.
Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G
World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers.
Maji A; Misra R; Dhakan DB; Gupta V; Mahato NK; Saxena R; Mittal P; Thukral N; Sharma E; Singh A; Virmani R; Gaur M; Singh H; Hasija Y; Arora G; Agrawal A; Chaudhry A; Khurana JP; Sharma VK; Lal R; Singh Y
Environ Microbiol; 2018 Jan; 20(1):402-419. PubMed ID: 29322681
[TBL] [Abstract][Full Text] [Related]
19. The gut and lung microbiota in pulmonary tuberculosis: susceptibility, function, and new insights into treatment.
Zhuo Q; Zhang X; Zhang K; Chen C; Huang Z; Xu Y
Expert Rev Anti Infect Ther; 2023; 21(12):1355-1364. PubMed ID: 37970631
[TBL] [Abstract][Full Text] [Related]
20. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death.
Xu R; Tan C; Zhu J; Zeng X; Gao X; Wu Q; Chen Q; Wang H; Zhou H; He Y; Pan S; Yin J
Crit Care; 2019 May; 23(1):195. PubMed ID: 31151471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
